You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

145 Items

An Endorsement of the 2021 Guideline on Chemotherapy in Combination with Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline

Document Status: Current
ID: GL END 5-7
Version: 3

Nov 2021

An Endorsement of the 2022 NCCN Guideline on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Document Status: Current
ID: GL-END-C50-35

Aug 2023

An Endorsement of the 2023 European Association of Urology (EAU) -American Society of Clinical Oncology (ASCO) Guidelines on Penile Cancer

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-2

Updated

Nov 2024

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Document Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025

An Endorsement of the ASCO-SNO Guideline on Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults

Document Status: Current
ID: GL END 9-10
Version: 2

Aug 2022

Approach to Fever Assessment in Ambulatory Cancer Patients Receiving Chemotherapy

Document Status: Current
ID: 12-15

Dec 2015

Best Practice Recommendations for Regimen Development and Maintenance

Document Status: Current
ID: GL-C50-25

Feb 2016

Biochemotherapy for the Treatment of Metastatic Malignant Melanoma

Document Status: Archived
ID: 8-3

Sep 2011

Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

Document Status: Current
ID: ES 23-2
Version: N/A

Jun 2020

Cancer Care Ontario Beyond-Use Date Recommendations Report

Document Status: Current
ID: N/A
Version: 1

Mar 2018

Cancer Care Ontario’s Focus on Take-Home Cancer Drugs and Community Practice

Document Status: Current
ID: GL-C50-17

Jan 2015

Capecitabine in Stage IV Breast Cancer

Document Status: Archived
ID: 1-16
Version: 2

Sep 2011